A recent report has revealed some concerning news for U.S. consumers: a 25% tariff on imported pharmaceutical products could ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...

China is not as big a player in the manufacturing of key ingredients used to make brand and generic medicines as previously ...

The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical ...

Mrs Aribeana noted that local manufacturing of pharmaceuticals also presents opportunities for job creation, international ...

CDMOs are crucial partners in alum-based vaccine production, managing aseptic filling with precision and efficiency.

LONDON] A 25 per cent US tariff on pharmaceutical imports would increase US drug costs by nearly US$51 billion annually, ...